logo

For the Inventor, By the Inventor

Salem, CT, United States of America

Ming Kang

This inventor holds 3 USPTO granted patents. Top assignee: Pfizer Corporation. Active years: 2004-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ming Kang. Retrieved from https://idiyas.com/inventor/ming-kang-qgc9bg3c

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3

Average Co-Inventor Count = 4.6

ph-index = 1


Company Filing History:

goldMedal3 out of 4,489 
 
Pfizer Corporation
 patents

Years Active: 2004-2005

Loading Chart...
3 patents (USPTO):Explore Patents
1. 6949652 - Crystalline forms of 3-isopropyl-6-[4-(2,5-difluoro-phenyl)-oxazol-5-yl]-[1,2,4]triazolo-[4,3-A]pyridine (2005-09-27),
2. 6919460 - Processes and intermediates useful in preparing β3-adrenergic receptor agonists (2005-07-19),
3. 6689888 - Processes and intermediates useful in preparing &bgr;3-adrenergic receptor agonists (2004-02-10),

Title: Innovations and Contributions of Inventor Ming Kang

Introduction

Ming Kang is a notable inventor based in Salem, Connecticut, who has made significant contributions to the field of pharmaceuticals. With a total of three patents to his name, he has focused on developing innovative solutions for various medical conditions.

Latest Patents

Ming Kang's latest patents include the invention of novel crystalline forms of 3-isopropyl-6-[4-(2,5-difluoro-phenyl)-oxazol-5-yl]-[1,2,4]triazolo-[4,3-a]pyridine. This compound is recognized for its potential as a potent inhibitor of MAP kinases, particularly p38 kinase, and is useful in treating inflammation, osteoarthritis, rheumatoid arthritis, cancer, and other disorders. Another significant patent involves processes and intermediates useful in preparing β3-adrenergic receptor agonists, which are essential for developing new therapeutic agents.

Career Highlights

Ming Kang is currently employed at Pfizer Corporation, where he continues to advance his research and development efforts. His work has contributed to the creation of pharmaceutical compositions that enhance treatment options for various health conditions.

Collaborations

Ming has collaborated with esteemed colleagues such as Yong Tao and Robert James Chambers, further enriching his research endeavors and expanding the impact of his inventions.

Conclusion

Ming Kang's innovative work in the pharmaceutical industry exemplifies the importance of research and development in creating effective treatments for complex medical issues. His contributions continue to influence the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…